Relation of cervical glandular intraepithelial neoplasia to microinvasive and invasive adenocarcinoma of the uterine cervix: A study of 121 cases

Journal of Clinical Pathology

Volumn 52, Issue 2, 1999, Pages 112-117

  Kurian, K ^a   Al Nafussi, A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Adenocarcinoma; Cervical glandular intraepithelial neoplasia; Cervix; Microinvasive adenocarcinoma

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; FEMALE; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; INCIDENCE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; UTERINE CERVIX CARCINOMA IN SITU;

EID: 0032940458     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.52.2.112     Document Type: Article

References (57)

1. 1 Stockton D, Cooper P, Lonsdale RN. Changing incidence of invasive adenocarcinoma of the uterine cervix in East Anglia. J Med Screen 1997;4:40-3.
2. 2 Parazzini F, La Vecchia C. Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol 1990;39:40-6.
3. 3 Leminen A, Paavonen J, Forss M, et al. Adenocarcinoma of the uterine cervix. Cancer 1990;65:53-9.
4. 4 Al-Nafussi A, McGoogan E. Auditing the smear histories of women with invasive cervical cancer for the years 1993, 1994, and 1995 in South East of Scotland [abstr]. Cytopathology 1996;1(suppl 1):7.
5. 5 Cullimore JE, Luesley DM, Rollason TP, et al. A prospective study of conization of the cervix in the management of cervical intraepithelial glandular neoplasia (CIGN) - a preliminary report. Br J Obstet Gynaecol 1992;99:314-18.
6. 6 Anderson MC. Glandular lesions of the cervix: diagnostic and therapeutic dilemmas. Baillieres Clin Obstet Gynaecol 1995;9:105-19.
7. 7 Gloor E, Hurlimann J. Cervical intra-epithelial glandular neoplasia (adenocarcinoma in situ and glandular dysplasia). Cancer 1986;58:1272-80.
8. 8 Brown JLR, Wells M. Cervical glandular atypia associated with squamous intraepithelial neoplasia: a premalignant lesion? J Clin Pathol 1986;39:229-9.
9. 9 Luesley DM, Jordan JA, Woodman CBJ, et al. A retrospective review of adenocarcinoma-in situ and glandular atypia of the uterine cervix. Br J Obstet Gynaecol 1987;94:699-703.
10. 10 Anderson MC, Fox H, Wells M, et al. Premalignant and malignant glandular lesions of the cervix. In: Haines and Taylor obstetrical and gynecologic pathology. New York: Churchill-Livingstone, 1995:273-364.
11. 11 Biscotti CV, Gero MA, Toddy SM, et al. Endocervical adenocarcinoma in situ: an analysis of cellular features. Diagn Cytopathol 1997;17:326-32.
12. 12 Jaworski RC. Endocervical glandular dysplasia, adenocarcinoma in situ, and early invasive (microinvasive) adenocarcinoma of the uterine cervix. Diagn Pathol 1990;7:190-204.
13. 13 Scully RE, Bonfiglio TA, Kurman RJ, et al. Histological typing of female genital tract tumours. WHO International histological classification of tumours, 2nd ed. Geneva: World Health Organisation, 1994: 43-4.
14. 14 Boon ME, Baak JPA, Kurver PJH, et al. Adenocarcinoma in situ of the cervix: an underdiagnosed lesion. Cancer 1981;48:768-73.
15. 15 Young RH, Clement PB, Scully RE. Premalignant and malignant glandular lesions of the uterine cervix. In: Clement PB, Young RH, eds. Tumors and tumor like lesions of the uterine corpus and cervix. New York: Churchill Livingstone, 1993.
16. 16 Gloor E, Ruzicka J. Morphology of adenocarcinoma in situ of the uterine cervix: a study of 14 cases. Cancer 1982;49:294-302.
17. 17 Boddington MM, Spriggs AI, Cowdell RH. Adenocarcinoma of the uterine cervix: cytological evidence of a long preclinical evolution. Br J Obstet Gynaecol 1976;83:900-3.
18. 18 Kashimura M, Shinohara M, Oikawa K, et al. An adenocarcinoma in situ of the uterine cervix that developed into invasive adenocarcinoma after 5 years. Gynecol Oncol 1990; 36:128-33.
19. 19 Cullimore JE, Luesley DM, Rollason TP, et al. A case of glandular intraepithelial neoplasia involving the cervix and vagina. Gynecol Oncol 1989;34:249-52.
20. 20 Hunter RW, Hammond IG. A case of multicentric glandular tumorigenesis of the female upper genital tract. Aust NZ J Obstet Gynaecol 1993;33:333-4.
21. 21 Casper GR, Ostor AG, Quinn MA. a clinicopathologic study of glandular dysplasia of the cervix. Gynecol Oncol 1997;64:166-70.
22. 22 Mulvany N, Ostor A. Microinvasive adenocarcinoma of the cervix: a cytohistopathologic study of 40 cases. Diagn Cytopathol 1997;16:430-6.
23. 23 Ostor A, Rome R, Quinn M. microinvasive adenocarcinoma of the cervix: a clinicopathologic study of 77 women. Obstet Gynecol 1997;89:88-93.
24. 24 Nakamima H. A clinicopathological study of early adenocarcinoma of the uterine cervix. Nagasaki Med J 1983;58: 218-33.
25. 25 Teshima S, Shimosato Y, Kishi K, et al. Early stage adenocarcinoma of the uterine cervix: histopathologic analysis with consideration of histogenesis. Cancer 1985;56: 167-72.
26. 26 Kaspar HG, Tung VD, Doherty MG, et al. Clinical implications of tumour volume measurement in stage I adenocarcinoma of the cervix. Obstet Gynecol 1993;81:296-9.
27. 27 Hoking GR, Hayman JA, Ostor AG. Adenocarcinoma in situ of the uterine cervix progressing to invasive adenocarcinoma. Aust NZ J Obstet Gynaecol 1996;36:167-72.
28. 28 Rollason TP, Cullimore J, Bradgate MG. A suggested columnar cell morphological equivalent of squamous carcinoma in situ with early stromal invasion. Int J Gynecol Pathol 1989;8:230-6.
29. 29 Cancer Committee of FIGO. Staging announcement. Gynecol Oncol 1986;25:383-5.
30. 30 Bousfield L, Pacey F, Young Q, et al. Expanded cytological criteria for the diagnosis of adenocarcinoma-in-situ of the cervix and related lesions. Acta Cytol 1980;24:283-95.
31. 31 Christopherson WM, Nealon N, Gray LA. Non-invasive precursor lesions and adenocarcinoma and mixed adenosquamous carcinoma of the cervix uteri. Cancer 1979;44: 975-83.
32. 32 Widrich T, Kennedy AW, Myers TM, et al. Adenocarcinoma in situ of the uterine cervix: management and outcome. Gynecol Oncol 1996;61:304-8.
33. 33 Howard G, Muntz HG. Can cervical adenocarcinoma in situ be safely managed by conization alone? Gynecol Oncol 1996;61:301-3.
34. 34 Young RH, Clement PB. Pseudoneoplastic glandular lesions of the uterine cervix. Semin Diagn Pathol 1991;8:234-49.
35. 35 Umezaki K, Sanezumi M, Okada H, et al. Distribution of epithelial-specific antigen in uterine cervix with endocervical glandular dysplasia. Gynecol Oncol 1997;66:393-8.
36. 36 Widrich T, Kennedy AW, Myers TM, et al. Adenocarcinoma in situ of the uterine cervix: management and outcome. Gynecol Oncol 1996;61:304-8.
37. 37 Bertrand M, Lickrish GM, Colgan TJ. The anatomic distribution of cervical adenocarcinoma in situ: implications for treatment. Am J Obstet Gynecol 1987;157:21-5.
38. 38 Ostor AG, Pagano R, Davoren RAM, et al. Adenocarcinoma in situ of the cervix. Int J Gynecol Pathol 1984;3:179-90.
39. 39 Nicklin JL, Wright RG, Bell JR, et al. A clinicopathological study of adenocarcinoma in situ of the cervix. The influence of cervical HPV infection and other factors, and the role of conservative surgery. Aust NZ J Obstet Gynaecol 1991;2:179-83.
40. 40 Muntz HG, Bell DA, Lage JM, et al. Adenocarcinoma in situ of the uterine cervix. Obstet Gynecol 1992;80:935-9.
41. 41 Qizilbash AH. In-situ and microinvasive adenocarcinoma of the uterine cervix. A clinical, cytologic and histologic study of 14 cases. Am J Clin Pathol 1975;64:155-70.
42. 42 Hopkins MP, Roberts JA, Schmidt RW. Cervical adenocarcinoma in situ. Obstet Gynecol 1988;71:842-4.
43. 43 Andersen EA, Arffmann E. Adenocarcinoma in situ of the uterine cervix: a clinico-pathologic study of 36 cases. Gynecol Oncol 1989;35:1-7.
44. 44 Poynor EA, Baraket RR, Hoskins WJ. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix. Gynecol Oncol 1995;57:158-64.
45. 45 Im DD, Duska LR, Rosenshein NB. Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease. Gynecol Oncol 1995;59:179-82.
46. 46 Gold M, Dunton CJ, Murray J, et al. Loop electrocautery excisional procedure: therapeutic effectiveness as an ablation and a conization equivalent. Gynecol Oncol 1996;61:241-4.
47. 47 Denehy TR, Gregori CA, Breen JL. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix. Obstet Gynecol 1997;90:1-6
48. 48 Houghton SJ, Shafi MI, Rollason TP, et al. Is loop excision adequate primary management of adenocarcinoma of the cervix? Br J Obstet Gynaecol 1997;104:325-9.
49. 49 Keyhani RS, Brewer J, Prokorym P. Comparative cytologic findings in situ and invasive adenocarcinoma of the uterine cervix. Diagn Cytopathol 1995;12:120-5.
50. 50 Laverty CR, Farnsworth A, Thurloe J, et al. The reliability of a cytological prediction of cervical adenocarcinoma in situ. Aust NZ J Obstet Gynaecol 1988;28:307-11.
51. 51 Siziopikou KP, Wang HH, Abu-Jawdeh G. Cytologic features of neoplastic lesions in endocervical glands. Diagn Cytopathol 1997;17:1-7.
52. 52 Jackson SR, Hollingworth TA, Anderson MC, et al. Glandular lesions of the cervix - cytological and histological correlation. Cytopathology 1996;7:10-16.
53. 53 Brinton LA, Herrerro R, Reeves WC, et al. Risk factors for cervical cancer by histology. Gynecol Oncol 1993;51:301-6.
54. 54 Pickel H. Adenocarcinoma in situ of the uterine cervix. Arch STD/HIV Res 1994;8:189-98.
55. 55 Duggan MA, McGregor SE, Benoit JL, et al. The human papillomavirus status of invasive cervical adenocarcinoma: a clinicopathological and outcome analysis. Hum Pathol 1995;26:319-25.
56. 56 Yamakawa Y, Forslund O, Teshima H, et al. Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction (PCR). Gynecol Oncol 1994;53:190-5.
57. 57 Parazzini F, La Vecchia C. Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol 1990;39:40-6.